BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,552,461 | -20.2% | 588,460 | +0.5% | 0.01% | -14.3% |
Q2 2023 | $37,016,050 | +42.4% | 585,697 | +1.4% | 0.01% | +40.0% |
Q1 2023 | $25,987,394 | +6.3% | 577,626 | +3.5% | 0.01% | 0.0% |
Q4 2022 | $24,441,073 | -33.1% | 557,888 | +0.6% | 0.01% | -37.5% |
Q3 2022 | $36,559,000 | +30.1% | 554,833 | -0.3% | 0.01% | +33.3% |
Q2 2022 | $28,107,000 | -24.1% | 556,462 | -4.0% | 0.01% | -14.3% |
Q1 2022 | $37,047,000 | -49.6% | 579,947 | -15.4% | 0.01% | -41.7% |
Q4 2021 | $73,442,000 | +1.2% | 685,669 | -2.8% | 0.01% | -7.7% |
Q3 2021 | $72,541,000 | +15.2% | 705,572 | -1.5% | 0.01% | +18.2% |
Q2 2021 | $62,976,000 | +0.4% | 715,960 | +11.0% | 0.01% | -8.3% |
Q1 2021 | $62,740,000 | -18.7% | 645,260 | -6.2% | 0.01% | -20.0% |
Q4 2020 | $77,184,000 | +17.9% | 688,215 | -2.6% | 0.02% | +7.1% |
Q3 2020 | $65,476,000 | +13.7% | 706,324 | -4.3% | 0.01% | 0.0% |
Q2 2020 | $57,574,000 | +41.2% | 738,134 | +5.9% | 0.01% | +16.7% |
Q1 2020 | $40,775,000 | -20.1% | 697,249 | +9.5% | 0.01% | +9.1% |
Q4 2019 | $51,024,000 | +7.5% | 636,936 | -1.4% | 0.01% | 0.0% |
Q3 2019 | $47,466,000 | -15.8% | 646,068 | +8.2% | 0.01% | -15.4% |
Q2 2019 | $56,349,000 | +34.9% | 597,366 | +14.5% | 0.01% | +30.0% |
Q1 2019 | $41,778,000 | +53.7% | 521,896 | +3.5% | 0.01% | +25.0% |
Q4 2018 | $27,190,000 | -33.1% | 504,348 | -3.2% | 0.01% | -20.0% |
Q3 2018 | $40,659,000 | +28.1% | 520,856 | +4.2% | 0.01% | +25.0% |
Q2 2018 | $31,735,000 | -30.4% | 499,911 | +0.6% | 0.01% | -33.3% |
Q1 2018 | $45,588,000 | +21.8% | 497,135 | +0.1% | 0.01% | +33.3% |
Q4 2017 | $37,434,000 | +15.0% | 496,409 | +6.3% | 0.01% | +12.5% |
Q3 2017 | $32,546,000 | +35.6% | 467,142 | -1.4% | 0.01% | +14.3% |
Q2 2017 | $23,995,000 | +95.8% | 473,545 | +54.5% | 0.01% | +75.0% |
Q1 2017 | $12,257,000 | +78.7% | 306,501 | +25.4% | 0.00% | +100.0% |
Q4 2016 | $6,858,000 | -2.7% | 244,493 | +3.0% | 0.00% | 0.0% |
Q3 2016 | $7,050,000 | +63.2% | 237,367 | +11.3% | 0.00% | +100.0% |
Q2 2016 | $4,320,000 | +112.2% | 213,313 | +89.1% | 0.00% | 0.0% |
Q1 2016 | $2,036,000 | -30.1% | 112,789 | +2.0% | 0.00% | 0.0% |
Q4 2015 | $2,912,000 | +28.3% | 110,542 | +4.0% | 0.00% | 0.0% |
Q3 2015 | $2,269,000 | +205.0% | 106,315 | +278.8% | 0.00% | – |
Q2 2015 | $744,000 | – | 28,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |